Neuropsychiatric aspects of Parkinson’s disease: Recent advances

被引：13
|
作者：
Laura Marsh
Ariel Berk
机构：
[1] Johns Hopkins University School of Medicine,Division of Psychiatric Neuroimaging, Geriatric and Neuropsychiatry Programs, Department of Psychiatry and Behavioral Sciences
来源：
Current Psychiatry Reports | 2003年 / 5卷 / 1期
关键词：
Levodopa; Clozapine; Anxiety Disorder; Selegiline; Subthalamic Nucleus;
D O I：
10.1007/s11920-003-0012-6
中图分类号：
学科分类号：
摘要：
Psychiatric disturbances are a common feature of Parkinson’s disease (PD), which is a degenerative disorder defined by its characteristic movement abnormalities. Its management is optimal when PD is viewed as a neuropsychiatric disorder, because this encourages consideration of the motor deficits along with its psychiatric and cognitive aspects. This review addresses the diagnosis and treatment of the most common psychiatric disorders in PD, and provides an update of related clinical research, including studies on neurosurgical treatments.
引用
收藏
页码：68 / 76
页数：8
相关论文
共 50 条
  • [21] Recent advances in the drug treatment of Parkinson's disease
    Poewe, W
    CURRENT OPINION IN NEUROLOGY, 1999, 12 (04) : 411 - 415
  • [22] Recent Advances in Drug Therapy for Parkinson?s Disease
    Murakami, Hidetomo
    Shiraishi, Tomotaka
    Umehara, Tadashi
    Omoto, Shusaku
    Iguchi, Yasuyuki
    INTERNAL MEDICINE, 2023, 62 (01) : 33 - 42
  • [23] Simultaneous bilateral subthalamotomies in Parkinson's disease: Neuropsychiatric and neuropsychological aspects
    Alvarez, L
    Casabona, E
    Leon, M
    Salazar, S
    Macias, R
    Litvan, I
    MOVEMENT DISORDERS, 2004, 19 : S259 - S259
  • [24] Parkinson's disease and parkinsonian syndroms: Recent advances in pharmacovigilance
    Montastruc, Jean-Louis
    Sommet, Agnes
    Olivier, Pascale
    Bagheri, Haleh
    Gony, Mireille
    Lapeyre-Mestre, Maryse
    Brefel-Courbon, Christine
    Ferreira, Joachim
    Schmitt, Laurent
    Senard, Jean-Michel
    Rascol, Olivier
    THERAPIE, 2006, 61 (01): : 29 - 38
  • [25] Recent advances in PET imaging for evaluation of Parkinson’s disease
    Chrissa Sioka
    Andreas Fotopoulos
    Athanassios P. Kyritsis
    European Journal of Nuclear Medicine and Molecular Imaging, 2010, 37 : 1594 - 1603
  • [26] Recent advances in dopaminergic strategies for the treatment of Parkinson's disease
    Mao, Qi
    Qin, Wang-zhi
    Zhang, Ao
    Ye, Na
    ACTA PHARMACOLOGICA SINICA, 2020, 41 (04): : 471 - 482
  • [27] Recent Advances in Rotigotine Nanoformulations for Parkinson's Disease Therapy
    Arora, Sanchit
    Gugulothu, Dalapathi
    BIONANOSCIENCE, 2025, 15 (02)
  • [28] Neurotoxic in vivo models of Parkinson's disease: recent advances
    Bjorklund, Anders
    Cenci, M. Angela
    RECENT ADVANCES IN PARKINSONS DISEASE: TRANSLATIONAL AND CLINICAL RESEARCH, 2010, 184 : 17 - 33
  • [29] Impulse control disorders in Parkinson's disease: recent advances
    Voon, Valerie
    Mehta, Arpan R.
    Hallett, Mark
    CURRENT OPINION IN NEUROLOGY, 2011, 24 (04) : 324 - 330
  • [30] Recent advances in PET imaging for evaluation of Parkinson's disease
    Sioka, Chrissa
    Fotopoulos, Andreas
    Kyritsis, Athanassios P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 (08) : 1594 - 1603
12345